Ketorolaco Guidelines and Considerations

Introduction to Ketorolaco Usage

The American College of Physicians recommends that ketorolaco treatment should be limited to a maximum of 5 days, combining all routes of administration, due to its potential for gastrointestinal bleeding and renal complications 1

The National Comprehensive Cancer Network recommends administering ketorolaco 15-30 mg IV every 6 hours for a maximum of 5 days for postoperative pain, with a daily dose considerably lower than other NSAIDs due to its higher potency and toxicity 1, 2

The American Family Physician suggests that ketorolaco is contraindicated in patients with a history of peptic ulcer disease or gastrointestinal bleeding, and should be used with extreme caution in patients with renal insufficiency, heart failure, or liver dysfunction 3
The National Comprehensive Cancer Network advises that ketorolaco should not be used in patients with advanced renal insufficiency or those at risk of renal failure due to volume depletion 1

The American Family Physician recommends monitoring blood pressure, BUN, creatinine, liver function tests, complete blood count, and stool occult blood test in patients taking ketorolaco, and discontinuing the medication immediately if creatinine levels double or if bleeding, new-onset hypertension, or liver enzyme elevation occurs 1, 3, 4

The American College of Physicians suggests that patients over 60 years old have a markedly increased risk of gastrointestinal bleeding and renal complications with ketorolaco, and should be treated with caution 1
The National Comprehensive Cancer Network recommends considering alternative analgesics, such as acetaminophen or COX-2 inhibitors with gastroprotection, in patients with high-risk factors 1, 3